Mucosal immunity induced by pneumococcal glycoconjugate (Q36260940)

13 August 2017

1 reference

title

Mucosal immunity induced by pneumococcal glycoconjugate (English)

1 reference

13 August 2017

Chi-Jen Lee

1

1 reference

13 August 2017

Lucia H Lee

series ordinal

2

1 reference

13 August 2017

Xin-Xing Gu

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Critical Reviews in Microbiology

13 August 2017

1 reference

13 August 2017

31

1 reference

13 August 2017

137-144

1 reference

13 August 2017

3

1 reference

Adenoviruses as vectors for delivering vaccines to mucosal surfaces

13 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

The role of helper T cell products in mouse B cell differentiation and isotype regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Breast milk anti-Escherichia coli heat-labile toxin IgA antibodies protect against toxin-induced infantile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Intermolecular cooperativity: a clue to why mice have IgG3?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Mucosal immunity: overcoming the barrier for induction of proximal responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Uptake and transport of intestinal macromolecules and microorganisms by M cells in Peyer's patches--a personal and historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

M cell in the immune system of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Genetic detoxification of bacterial toxins: a new approach to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Human IgA activates the complement system via the mannan-binding lectin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Immunomodulation using bacterial enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Advances in vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Mucosal immunity to infection with implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Structure and function of human and murine receptors for IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

Pneumococcal virulence factors and host immune responses to them

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408410591005093

10.1080/10408410591005093

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference